Bright Green (BGXX) Competitors $0.08 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BGXX vs. ENTX, MURA, AFMD, STTK, THTX, ATNM, CNTB, AADI, ATRA, and KRONShould you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include Entera Bio (ENTX), Mural Oncology (MURA), Affimed (AFMD), Shattuck Labs (STTK), Theratechnologies (THTX), Actinium Pharmaceuticals (ATNM), Connect Biopharma (CNTB), Aadi Bioscience (AADI), Atara Biotherapeutics (ATRA), and Kronos Bio (KRON). These companies are all part of the "pharmaceutical products" industry. Bright Green vs. Entera Bio Mural Oncology Affimed Shattuck Labs Theratechnologies Actinium Pharmaceuticals Connect Biopharma Aadi Bioscience Atara Biotherapeutics Kronos Bio Bright Green (NASDAQ:BGXX) and Entera Bio (NASDAQ:ENTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Which has better earnings & valuation, BGXX or ENTX? Entera Bio has higher revenue and earnings than Bright Green. Entera Bio is trading at a lower price-to-earnings ratio than Bright Green, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBright GreenN/AN/A-$13.13M-$0.06-1.30Entera Bio$130K476.15-$8.89M-$0.26-6.65 Do analysts recommend BGXX or ENTX? Entera Bio has a consensus price target of $10.00, suggesting a potential upside of 478.03%. Given Entera Bio's stronger consensus rating and higher probable upside, analysts clearly believe Entera Bio is more favorable than Bright Green.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bright Green 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Entera Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, BGXX or ENTX? Bright Green has a beta of -0.28, suggesting that its stock price is 128% less volatile than the S&P 500. Comparatively, Entera Bio has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Does the MarketBeat Community favor BGXX or ENTX? Entera Bio received 179 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformBright GreenN/AN/AEntera BioOutperform Votes17967.55% Underperform Votes8632.45% Do insiders & institutionals believe in BGXX or ENTX? 7.8% of Bright Green shares are held by institutional investors. Comparatively, 14.1% of Entera Bio shares are held by institutional investors. 62.6% of Bright Green shares are held by insiders. Comparatively, 10.9% of Entera Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is BGXX or ENTX more profitable? Bright Green's return on equity of -83.40% beat Entera Bio's return on equity.Company Net Margins Return on Equity Return on Assets Bright GreenN/A -83.40% -53.83% Entera Bio N/A -107.24%-92.29% Does the media prefer BGXX or ENTX? In the previous week, Entera Bio had 9 more articles in the media than Bright Green. MarketBeat recorded 9 mentions for Entera Bio and 0 mentions for Bright Green. Bright Green's average media sentiment score of 0.00 beat Entera Bio's score of -0.17 indicating that Bright Green is being referred to more favorably in the media. Company Overall Sentiment Bright Green Neutral Entera Bio Neutral SummaryEntera Bio beats Bright Green on 9 of the 15 factors compared between the two stocks. Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Get Bright Green News Delivered to You Automatically Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGXX vs. The Competition Export to ExcelMetricBright GreenMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.91M$1.33B$5.15B$8.74BDividend YieldN/AN/A5.18%4.08%P/E Ratio-1.3024.0266.3713.55Price / SalesN/A7.641,276.8487.67Price / CashN/A11.9439.7035.24Price / Book1.301.956.475.93Net Income-$13.13M-$52.95M$119.73M$225.73M7 Day PerformanceN/A-2.37%-5.13%-1.34%1 Month PerformanceN/A-2.50%-2.71%1.15%1 Year PerformanceN/A7.07%31.08%24.02% Bright Green Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGXXBright GreenN/A$0.08flatN/A-76.7%$14.91MN/A-1.302Upcoming EarningsGap DownENTXEntera Bio1.6846 of 5 stars$1.70flatN/A+137.1%$60.83M$130,000.00-6.5420Short Interest ↑Analyst RevisionNews CoverageMURAMural Oncology3.0239 of 5 stars$3.48-3.9%N/AN/A$59.30MN/A-0.34119Analyst RevisionGap DownAFMDAffimed3.5511 of 5 stars$3.83+0.3%N/A-5.9%$58.33M$8.95M0.0076Analyst ForecastNews CoverageSTTKShattuck Labs3.0576 of 5 stars$1.22+3.4%N/A-40.3%$58.23M$4.12M-0.66100Analyst ForecastAnalyst RevisionNews CoverageTHTXTheratechnologiesN/A$1.26flatN/A-5.6%$57.94M$84.32M-12.60140Short Interest ↑News CoverageATNMActinium Pharmaceuticals1.6219 of 5 stars$1.86-3.9%N/AN/A$57.88M$80,000.00-1.2349Analyst ForecastNews CoverageCNTBConnect Biopharma3.7614 of 5 stars$1.02-2.9%N/A-44.2%$56.36MN/A0.00110Short Interest ↓News CoverageGap UpAADIAadi Bioscience3.0453 of 5 stars$2.28+8.6%N/A-53.4%$56.20M$24.35M-1.0040ATRAAtara Biotherapeutics3.8526 of 5 stars$11.30-4.0%N/A-0.1%$55.48M$8.57M-0.29165Earnings ReportAnalyst ForecastNews CoverageKRONKronos Bio3.2326 of 5 stars$0.91+4.4%N/A-19.8%$54.86M$6.29M-0.52100Analyst DowngradeNews CoverageGap Down Related Companies and Tools Related Companies ENTX Alternatives MURA Alternatives AFMD Alternatives STTK Alternatives THTX Alternatives ATNM Alternatives CNTB Alternatives AADI Alternatives ATRA Alternatives KRON Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGXX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Green Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Green With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
